semaglutide tirzepatide weight loss comparison vs. Semaglutide: What's the Difference? Weight loss with retatrutide1, tirazepatide2,

How It Works Activates both GLP-1 and GIP receptors for a broader metabolic impact Reduces appetite and increases satiety through two hormonal pathways Enhances insulin sensitivity more aggressively than GLP-1 alone Supports reduction of visceral fat the deep abdominal fat most strongly associated with metabolic disease Improves blood sugar regulation through a dual insulin-stimulating mechanism Clinical Results In the SURMOUNT-1 trial, Tirzepatide produced average weight loss of up to 20% of body weight outperforming Semaglutide in head-to-head comparisons

Retatrutide targets three receptors (GLP-1 + GIP + glucagon) and achieved 24.2% mean weight loss at 48 weeks in Phase 2

R.OwensD

The findings were also published in Psychoneuroendocrinology